纳米医学近期的进步设计了针对亚细胞结构的策略
Defeng Ye1, Hua Liu1, Enci Dai2
1Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
iScience
|January 15, 2025
概括
纳米医学提供先进的癌症治疗,通过精确地准瘤内的亚细胞结构. 本综述探讨了用于改善癌症治疗的纳米药物输送系统的最新进展.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 传统的癌症治疗因副作用和疗效问题而面临限制.
- 纳米技术为克服癌症治疗中的这些挑战提供了一个有希望的途径.
- 纳米医学利用各种向策略来增强药物输送.
研究的目的:
- 在过去五年中,审查细胞下结构向纳米药物的进展.
- 突出设计策略,以准瘤细胞内的特定细胞器.
- 讨论纳米药物研究的现状,局限性和未来前景.
主要方法:
- 在过去五年内发表的纳米药物研究的文献综述.
- 对纳米药物设计策略的分析,以准线粒体,溶解体,内分泌网膜,戈尔吉器官和细胞骨.
- 关于纳米药物技术从第一代到第三代演变的信息综合.
主要成果:
- 纳米药物正在向精确的输送方向发展,准亚细胞组件以提高疗效.
- 已开发出针对线粒体,溶酶体,ER,戈尔吉和细胞骨的特定设计策略.
- 第一到第三代纳米药物在药物输送方面表现出越来越高的精度.
结论:
- 针对细胞下结构的纳米药物代表了癌症治疗的重大进步.
- 需要进一步的研究来克服目前的局限性,并充分实现纳米医学的潜力.
- 未来的方向包括完善向策略和开发下一代纳米药物用于个性化癌症治疗.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...